Skip to content

Drug interactions

Dactinomycin + Olaparib

Severity: Moderate

Dactinomycin and Olaparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs suppress bone marrow function, and dactinomycin also damages DNA. Used together they can deepen and prolong anemia, neutropenia and thrombocytopenia beyond what either drug causes alone.

What this interaction means in plain words

Dactinomycin and Olaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dactinomycin belongs to Oncology; Olaparib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic myelosuppression from a DNA-damaging cytotoxic combined with a PARP inhibitor.

What to do

Monitor complete blood counts frequently during combined treatment. Delay cycles or reduce doses of either drug if significant cytopenias develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dactinomycin and Olaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dactinomycin with Olaparib?

MediHelp rates the interaction as moderate. Dactinomycin and Olaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs suppress bone marrow function, and dactinomycin also damages DNA. Used together they can deepen and prolong anemia, neutropenia and thrombocytopenia beyond what either drug causes alone.

How serious is the interaction between Dactinomycin and Olaparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts frequently during combined treatment. Delay cycles or reduce doses of either drug if significant cytopenias develop.

What other medicines interact with Dactinomycin?

MediHelp also lists interactions of Dactinomycin with, for example, Adenovirus types 4 and 7 live, Belatacept, Dengue vaccine. The full list is on the Dactinomycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in